What is the recommended Digibind (digoxin‑specific antibody fragments) dose for acute and chronic digoxin overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Digibind Dosing for Digoxin Overdose

For life-threatening digoxin toxicity, administer digoxin-specific antibody fragments (Digibind/DigiFab) using one of three dosing strategies: 2 vials per milligram of known ingested digoxin in acute overdose, the formula [serum digoxin (ng/mL) × weight (kg) / 100] for chronic toxicity with known levels, or empirically 10-20 vials when levels are unavailable in critical cases. 1

Indications for Digibind Administration

Class I indication (must give):

  • Life-threatening ventricular arrhythmias (VT, VF) 1, 2
  • Progressive bradyarrhythmias or high-degree AV block 1, 3
  • Cardiac arrest from digoxin toxicity 1, 2
  • Serum potassium >5.0 mEq/L in acute poisoning 1
  • Serum digoxin >10 ng/mL 4
  • Ingestion >10 mg in adults or >4 mg in children 4

Dosing Strategies by Clinical Scenario

Acute Overdose with Known Ingested Dose

  • Administer 2 vials of Fab for every 1 mg of digoxin ingested 1
  • Each 40 mg vial neutralizes 0.5 mg digoxin 1, 5
  • This calculation typically overestimates need due to incomplete absorption (60-80% bioavailability), vomiting, and activated charcoal binding 6

Chronic Toxicity with Known Serum Level

  • Use formula: Number of vials = [serum digoxin concentration (ng/mL) × weight (kg)] / 100 1
  • Sample digoxin level at least 6-8 hours post-dose to allow tissue distribution 4
  • Levels drawn before distribution is complete (within 6 hours) will overestimate required dose 6, 7

Critical Cases Without Available Levels

  • Administer empirically 10-20 vials immediately 1
  • This approach is justified when life-threatening toxicity exists and waiting for laboratory results would delay treatment 1

Evidence-Based Alternative: Fractional Dosing

Recent evidence suggests calculated full neutralizing doses are excessive and more cost-effective strategies exist:

For Acute Poisoning:

  • Give 80 mg (2 vials) as initial bolus, repeat as needed based on clinical response 6
  • Most patients require less than half the calculated neutralizing dose using this strategy 6
  • Clinical response typically occurs within 30-45 minutes 3, 2, 6
  • Rationale: Only need to neutralize digoxin in central compartment (Vd ≈55L) rather than total body stores 6

For Chronic Poisoning:

  • Give 40 mg (1 vial) initially, repeat after 60 minutes if symptomatic 6, 7
  • Average requirement is 3 vials (range 1-6 vials) based on retrospective analysis 8
  • Most patients need 40-120 mg (1-3 vials) total 6
  • Empiric dosing recommendations of 3-6 vials overestimate actual requirements 8

Clinical Response and Monitoring

Expected timeline:

  • Free digoxin concentration falls to near-zero within minutes of Fab administration 6
  • Clinical improvement (arrhythmia resolution) occurs in 30 minutes to 4 hours 1, 3, 9, 2
  • Response rates of 50-90% reported in severe toxicity 3, 9, 2
  • In cardiac arrest from digoxin, 54% survival to hospital discharge reported 1, 3, 9

Monitor for:

  • Recrudescence of toxicity 8-12 hours post-treatment (may require additional dosing) 6, 10
  • Hypokalemia (common adverse effect) 3, 9, 5
  • Worsening heart failure or increased ventricular rate in atrial fibrillation 3, 9
  • Serum digoxin levels become unreliable after Fab administration 3, 9

Pharmacokinetic Considerations

  • Digoxin-Fab half-life: 19-30 hours (prolonged to >100 hours in renal failure) 6
  • Renal clearance of bound digoxin: 13.6 mL/min 10
  • Volume of distribution of Fab: 0.4 L/kg, suggesting intracellular penetration 6, 10
  • Tissue redistribution of digoxin occurs over hours after initial Fab binding 7, 10

Critical Pitfalls to Avoid

Do NOT give potassium supplementation in acute massive overdose - hyperkalemia from cellular shift is marker of severity and potassium administration is hazardous 1, 4

Do NOT use dialysis, hemofiltration, or plasmapheresis - these modalities are ineffective for digoxin removal and not recommended 5, 2

Do NOT delay treatment waiting for digoxin levels in life-threatening presentations - give empiric dose immediately 1

Do NOT use lidocaine or phenytoin as primary therapy - these have no role in modern management; Digibind is treatment of choice 3, 9

Special Populations

  • Renal dysfunction: Use conservative peak body stores (6-10 mcg/kg vs 8-12 mcg/kg) for dose calculations 4
  • Other cardiac glycosides: Digibind reasonable for Bufo toad venom and yellow oleander poisoning 2
  • Pediatric patients: Ingestion >4 mg warrants Digibind consideration 4

References

Research

Digoxin-specific antibody fragments in the treatment of digoxin toxicity.

Clinical toxicology (Philadelphia, Pa.), 2014

Research

Digoxin-Specific Antibody Fragment Dosing: A Case Series.

American journal of therapeutics, 2016

Related Questions

What should I do if I missed a dose of digoxin (digitalis) and then took a double dose, now experiencing shortness of breath (dyspnea) and fatigue?
What are the signs and symptoms of Digoxin (digitalis glycoside) toxicity?
What should be done for a patient experiencing fatigue and shortness of breath (SOB) with electrocardiogram (ECG) changes showing marked mid and left precordial repolarization disturbance after taking a double dose of digoxin (digitalis glycoside)?
What are the management steps for a patient with elevated digoxin (digitalis glycoside) level of 2.56 ng/mL, indicating potential digoxin toxicity?
Should digoxin be stopped if a patient develops nausea, vomiting, and dizziness?
Which ICD‑10 code should I use to order vitamin B12, folate, vitamin D, ferritin, and iron labs for a 69‑year‑old man with type 2 diabetes mellitus and hyperlipidemia who has no fatigue?
How often should a 12‑lead ECG be performed to monitor a patient with anorexia nervosa, BMI 16.9, and a resting heart rate of 32 bpm?
Why does a prolonged vasovagal response occur after drinking and eating?
What are the most common causes of death in patients with cellulitis?
Is duloxetine effective for treating neuropathic pain?
What is the infusion rate (milliequivalents per hour) for potassium chloride when 40 mEq is mixed in 1 L normal saline and administered over 16 hours, what increase in serum potassium concentration is expected, and how frequently should serum potassium be monitored during the infusion?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.